THE MCLEAN HOSPITAL CORPORATION
BELMONT, MASSACHUSETTS 024781041
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $15.16M | 9 |
| 541715 | $3.45M | 8 |
| 621511 | $256K | 4 |
| 541990 | $-681.3 | 1 |
| 541712 | $-22,612.04 | 3 |
| 622210 | $-59,931.6 | 1 |
Contract Awards
18 awards found
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY (NBB)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRESERVE, AND DISTRIBUTE CNS AND RELATED
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2023.
EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI. ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS.
DOE, MCLEAN HOSPITAL, BENZODIAZEPINE TESTING
NIH NATIONAL BRAIN AND TISSUE REPOSITORY
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS.
NIH NATIONAL BRAIN AND TISSUE REPOSITORY PERIOD OF PERFORMANCE: 09/01/2019 - 08/31/2021 (UNCHANGED) TOTAL CONTRACT AMOUNT: $4,937,543.50 (UNCHANGED) TOTAL OBLIGATED AMOUNT: $4,937,543.50 (UNCHANGED)
TITLE: DOE, MCLEAN HOSPITAL, BENZODIAZEPINE TESTING REQUESTOR: CASSANDRA PRIOLEAU REF AWARD/BPA: 15DDHQ23Q00000149 POP DATES: 07/18/2024 TO 07/17/2025 DELIVERY DATE: 07/18/2024
NIH NATIONAL BRAIN AND TISSUE REPOSITORY PERIOD OF PERFORMANCE: 09/01/2019 - 08/31/2021 (UNCHANGED) TOTAL CONTRACT AMOUNT: $4,937,543.50 (UNCHANGED) TOTAL OBLIGATED AMOUNT: $4,937,543.50 (UNCHANGED)
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2023.
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS.
NIH NATIONAL BRAIN AND TISSUE REPOSITORY PERIOD OF PERFORMANCE: 09/01/2019 - 08/31/2021 (UNCHANGED) TOTAL CONTRACT AMOUNT: $4,937,543.50 (UNCHANGED) TOTAL OBLIGATED AMOUNT: $4,937,543.50 (UNCHANGED)
ASSESSMENT OF POTENTIAL COCAINE TREATMENT MEDICATIONS IN NON-HUMAN PRIMATES
EO14042 - MRS SCANNING SERVICES
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2023.
NIH NATIONAL BRAIN AND TISSUE REPOSITORY PERIOD OF PERFORMANCE: 09/01/2019 - 08/31/2021 (UNCHANGED) TOTAL CONTRACT AMOUNT: $4,937,543.50 (UNCHANGED) TOTAL OBLIGATED AMOUNT: $4,937,543.50 (UNCHANGED)
'TESTMYBRAIN' DESIGN CONSULTING FOR RESEARCH DOMAIN (RDOC) CRITERIA FIELD TEST BATTERY SERVICES SUPPORT FOR THE NATIONAL INSTITUTE OF MENTAL HEALTH (NIMH)
ASSESSMENT OF POTENTIAL SUBSTANCE ABUSE TREATMENT MEDICATIONS IN NONHUMAN PRIMATE MODELS. NIDA REF. NO. N01DA-19-8946; POP: 12/16/2018-12/15/2022.
Business Details
- UEI
- MCKWJYCWNVN3
- CAGE Code
- 1F6D4
- Address
- 115 MILL ST
BELMONT, MA 024781041 - Congressional District
- MA-05
- Phone
- 6178552922
Parent Company
PARTNERS HEALTHCARE SYSTEM, INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov